Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-24 @ 4:03 PM
Ignite Modification Date: 2025-12-25 @ 2:05 PM
NCT ID: NCT01458366
Term: Anemia
Organ System: Blood and lymphatic system disorders
Assessment Type: NON_SYSTEMATIC_ASSESSMENT
Source Vocabulary: None
Notes: None
Study: NCT01458366
Study Brief: Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG001 0 0 0 View
EG000 23 3 5 View
EG002 17 2 3 View
EG003 13 3 3 View
EG004 17 11 27 View